Total Payments
$42,353
2024 Payments
$890.52
Companies
42
Transactions
682
Medicare Patients
10,661
Medicare Billing
$2.7M
Payment Breakdown by Category
Other$28,000 (66.1%)
Food & Beverage$11,849 (28.0%)
Travel$2,480 (5.9%)
Education$24.19 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,000 | 1 | 59.0% |
| Food and Beverage | $11,849 | 646 | 28.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,000 | 1 | 7.1% |
| Travel and Lodging | $2,480 | 10 | 5.9% |
| Education | $24.19 | 24 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $25,645 | 33 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $4,047 | 16 | $0 (2017) |
| Abbott Laboratories | $3,614 | 94 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,343 | 85 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $1,042 | 69 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $658.70 | 54 | $0 (2022) |
| Nevro Corp. | $523.96 | 14 | $0 (2023) |
| PFIZER INC. | $510.74 | 30 | $0 (2020) |
| Assertio Therapeutics, Inc. | $440.91 | 25 | $0 (2020) |
| Lilly USA, LLC | $408.02 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.52 | 28 | Medtronic, Inc. ($305.88) |
| 2023 | $997.43 | 45 | Abbott Laboratories ($289.53) |
| 2022 | $3,551 | 79 | Abbott Laboratories ($2,190) |
| 2021 | $2,080 | 122 | Abbott Laboratories ($653.03) |
| 2020 | $25,953 | 64 | Boston Scientific Corporation ($25,051) |
| 2019 | $1,555 | 91 | ASSERTIO THERAPEUTICS, Inc. ($230.62) |
| 2018 | $1,421 | 96 | Collegium Pharmaceutical, Inc. ($233.85) |
| 2017 | $5,906 | 157 | Valeant Pharmaceuticals North America LLC ($4,047) |
All Payment Transactions
682 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Analgesic | ||||||
| 11/19/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Analgesic | ||||||
| 11/13/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $129.20 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.28 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Neuromodulation | ||||||
| 10/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Neuromodulation | ||||||
| 10/01/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Analgesic | ||||||
| 07/22/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $262.15 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/10/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Analgesic | ||||||
| 06/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Opioid Analgesic | ||||||
| 06/17/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Not Applicable | ||||||
| 06/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/30/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/13/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Not Applicable | ||||||
| 05/09/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Analgesic | ||||||
| 05/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/23/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Analgesic | ||||||
| 03/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.93 | General |
| Category: Opioid Analgesic | ||||||
| 03/18/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $40.29 | General |
| 03/11/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Analgesic | ||||||
| 03/08/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Neuromodulation | ||||||
| 02/01/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 01/29/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,164 | 10,640 | $5.0M | $776,102 |
| 2022 | 19 | 2,817 | 10,292 | $4.4M | $710,961 |
| 2021 | 18 | 2,490 | 9,551 | $3.9M | $699,777 |
| 2020 | 15 | 2,190 | 8,490 | $3.3M | $536,701 |
Total Patients
10,661
Total Services
38,973
Medicare Billing
$2.7M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 481 | 1,898 | $738,387 | $216,734 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 514 | 1,842 | $549,732 | $146,895 | 26.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 282 | 497 | $944,300 | $117,449 | 12.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 282 | 497 | $670,453 | $53,904 | 8.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 125 | 214 | $555,330 | $52,962 | 9.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 90 | 141 | $228,843 | $29,490 | 12.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 185 | 185 | $114,515 | $27,985 | 24.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 55 | 93 | $276,175 | $23,403 | 8.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 33 | 44 | $85,976 | $19,504 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 185 | 185 | $73,815 | $18,675 | 25.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 118 | 277 | $83,100 | $16,999 | 20.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 90 | 141 | $119,004 | $15,394 | 12.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 33 | 44 | $56,100 | $10,988 | 19.6% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 40 | 131 | $26,200 | $7,585 | 29.0% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 15 | 25 | $18,725 | $5,375 | 28.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 59 | 90 | $70,650 | $5,120 | 7.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 551 | 4,305 | $322,875 | $3,641 | 1.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 13 | 18 | $22,644 | $2,833 | 12.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 13 | 13 | $33,735 | $1,167 | 3.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 441 | 1,647 | $642,330 | $186,522 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 527 | 1,819 | $542,984 | $149,118 | 27.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 243 | 443 | $841,700 | $109,346 | 13.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 121 | 211 | $547,545 | $54,701 | 10.0% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 243 | 443 | $597,607 | $50,476 | 8.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 161 | 161 | $99,659 | $24,597 | 24.7% |
About Dr. Scott Gottlieb, M.D
Dr. Scott Gottlieb, M.D is a Pain Medicine healthcare provider based in Pearl River, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720185515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Gottlieb, M.D has received a total of $42,353 in payments from pharmaceutical and medical device companies, with $890.52 received in 2024. These payments were reported across 682 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,000).
As a Medicare-enrolled provider, Gottlieb has provided services to 10,661 Medicare beneficiaries, totaling 38,973 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Pearl River, NY
- Active Since 09/20/2006
- Last Updated 11/17/2015
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720185515
Products in Payments
- GENERAL - THERAPIES (Device) $25,000
- SILIQ (Drug) $3,910
- PROCLAIM (Device) $1,661
- XTAMPZA (Drug) $901.27
- AXIUM (Device) $758.39
- Horizant (Drug) $713.72
- ZTLido (Drug) $679.70
- Proclaim IPG (Device) $435.65
- LYRICA (Drug) $422.41
- Movantik (Drug) $369.70
- INTELLIS ADAPTIVESTIM (Device) $366.35
- Proclaim Family of SCS IPGs (Device) $320.96
- Gralise (Drug) $289.51
- Omnia (Device) $253.97
- DUEXIS (Drug) $252.49
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $247.79
- RELISTOR (Drug) $233.06
- Nucynta (Drug) $205.09
- MOVANTIK (Drug) $180.62
- GRALISE (Drug) $178.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.